Non-statin cholesterol drugs on SilverScript Choice (S5601-008)
Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), New Jersey
- Premium
- $97.40/month
- Deductible
- $615.00
6 of 8 Non-statin cholesterol drugs are covered on this plan. 1 of them require prior authorization.
2 aren't on the formulary (Praluent and icosapent ethyl).
- 33%Tier 4
- 18%Tier 3
- $76.64Tier 3
- $76.64Tier 3
- $7.00Tier 2
- 33%Tier 4
Not on the formulary
Praluent, icosapent ethyl
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.